Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (111-120 of 369) with videos related to

Pageof 37
Sort By:
Cancer|February 10, 2017
Words matter: Restoring respect and dignity when referring to individuals with cancerLee M Ellis, Charles D Blanke, Elise C Kohn
Toxicology and Applied Pharmacology|November 14, 1997
A mathematical model of production, distribution, and metabolism of melatonin in mammalian systemsG M Blumenthal, M C Kohn, C J Portier
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Proteomic analysis for early detection of ovarian cancer: a realistic approach?E V Stevens, L A Liotta, E C Kohn
Cancer|January 5, 2000
The new millennium: applying novel technology to the study of the cancer cell in situM R Brown, E C Kohn, R V Hutter
Proteomics|October 24, 2007
Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarraysMary Winters, Bhavana Dabir, Minshu Yu, et al.
Hospital Practice (Office Ed.)|May 15, 1993
Cancer invasion and metastasisY S Kim, L A Liotta, E C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
The <i>HRD</i> Decision<i>-</i>Which PARP Inhibitor to Use for Whom and WhenElise C Kohn, Jung-Min Lee, S Percy Ivy
Drug Discovery Today|September 11, 2007
The ongoing evolution of proteomics in malignancyAmit S Dhamoon, Elise C Kohn, Nilofer S Azad
European Journal of Nuclear Medicine|April 1, 2000
The new millennium: applying novel technology to the study of the cancer cell in situM R Brown, E C Kohn, R V Hutter
Environmental Health Perspectives|March 1, 1996
Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesisR L Melnick, M C Kohn, C J Portier
Pageof 37

Showing results (111-120 of 369) with videos related to

Sort By:
Pageof 37
Cancer|February 10, 2017
Words matter: Restoring respect and dignity when referring to individuals with cancerLee M Ellis, Charles D Blanke, Elise C Kohn
Toxicology and Applied Pharmacology|November 14, 1997
A mathematical model of production, distribution, and metabolism of melatonin in mammalian systemsG M Blumenthal, M C Kohn, C J Portier
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Proteomic analysis for early detection of ovarian cancer: a realistic approach?E V Stevens, L A Liotta, E C Kohn
Cancer|January 5, 2000
The new millennium: applying novel technology to the study of the cancer cell in situM R Brown, E C Kohn, R V Hutter
Proteomics|October 24, 2007
Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarraysMary Winters, Bhavana Dabir, Minshu Yu, et al.
Hospital Practice (Office Ed.)|May 15, 1993
Cancer invasion and metastasisY S Kim, L A Liotta, E C Kohn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
The <i>HRD</i> Decision<i>-</i>Which PARP Inhibitor to Use for Whom and WhenElise C Kohn, Jung-Min Lee, S Percy Ivy
Drug Discovery Today|September 11, 2007
The ongoing evolution of proteomics in malignancyAmit S Dhamoon, Elise C Kohn, Nilofer S Azad
European Journal of Nuclear Medicine|April 1, 2000
The new millennium: applying novel technology to the study of the cancer cell in situM R Brown, E C Kohn, R V Hutter
Environmental Health Perspectives|March 1, 1996
Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesisR L Melnick, M C Kohn, C J Portier
Pageof 37